CERS vs RVTY · rev $111.1M vs P/E 42, rev $1.44B
Cerus Corporation (CERS) versus Revvity Inc. (RVTY) — a side-by-side from cached financials, not a winner call.
Cerus Corporation (CERS) is a medical devices company listed on US.
Revvity Inc. (RVTY) is a diagnostics & research company listed on US.
Latest reported CERS revenue for 2026-06-30 was $111.1M. Net income was -$4.6M. CERS currently screens at market cap $294.4M.
Latest reported RVTY revenue for 2026-07-05 was $1.44B. Net income was $92.5M. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
CERS currently screens at market cap $294.4M. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
Not investment advice. Open the CERS and RVTY stock pages for the full models.
Not investment advice.